Litcius/Paper detail

Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4

Romain‐David Seban, Antoine Moya‐Plana, Lara Antonios, Randy Yeh, Aurélien Marabelle, Éric Deutsch, Lawrence H. Schwartz, Ruth Gabriela Herrera Gómez, Yvonne M. Saenger, Caroline Robert, Samy Ammari, Laurent Dercle

2020European Journal of Nuclear Medicine and Molecular Imaging81 citationsDOI

Topics & Concepts

MedicineMelanomaNuclear medicineInternal medicineStandardized uptake valueGastroenterologyPositron emission tomographyOncologyCancer researchCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementLung Cancer Diagnosis and Treatment
Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4 | Litcius